Ionis Pharmaceuticals, Inc. (IONS) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 7.20B USD. 52-week range 42.63 to 86.74 USD. Data as of 2026-10-09.
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; DAWNZERA for prophylaxis to prevent attacks of hereditary angioedema in adults; WAINUA for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults; and SPINRAZA for pediatric and adult ...